Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Intangibles: 2023-2024

  • Mirum Pharmaceuticals' Change in Intangibles was N/A to $10.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $40.0 million, marking a year-over-year change of. This contributed to the annual value of $20.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2024, Mirum Pharmaceuticals' Change in Intangibles stood at $10.0 million, which was down 0.00% from $10.0 million recorded in Q2 2024.
  • In the past 5 years, Mirum Pharmaceuticals' Change in Intangibles ranged from a high of $15.0 million in Q1 2023 and a low of $5.0 million during Q4 2023.
  • Its 2-year average for Change in Intangibles is $10.0 million, with a median of $10.0 million in 2024.